BIOMAT Database Logo BIOMAT Database Logo

Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, and Y. 1978

J D Farquhar, and W A Hankins, and A N Desanctis, and J L Demeio, and D P Metzgar

UI MeSH Term Description Entries
D009345 Neisseria meningitidis A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype. Diplokokkus intracellularis meningitidis,Meningococcus,Micrococcus intracellularis,Micrococcus meningitidis,Micrococcus meningitidis cerebrospinalis,Neisseria weichselbaumii
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial

Related Publications

J D Farquhar, and W A Hankins, and A N Desanctis, and J L Demeio, and D P Metzgar
Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W 135: clinical and serological evaluation.
October 1982, Journal of biological standardization,
J D Farquhar, and W A Hankins, and A N Desanctis, and J L Demeio, and D P Metzgar
Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
March 2006, Vaccine,
J D Farquhar, and W A Hankins, and A N Desanctis, and J L Demeio, and D P Metzgar
Clinical and laboratory investigations of monovalent and combined meningococcal polysaccharide vaccine, groups A and C.
December 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J D Farquhar, and W A Hankins, and A N Desanctis, and J L Demeio, and D P Metzgar
Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
October 2016, Vaccine,
J D Farquhar, and W A Hankins, and A N Desanctis, and J L Demeio, and D P Metzgar
[Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].
August 1982, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau,
J D Farquhar, and W A Hankins, and A N Desanctis, and J L Demeio, and D P Metzgar
[Evaluation on the safety of a group A + C meningococcal polysaccharide vaccine].
May 2007, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
J D Farquhar, and W A Hankins, and A N Desanctis, and J L Demeio, and D P Metzgar
[Meningococcal C polysaccharide vaccine in Andalucia].
December 2000, Anales espanoles de pediatria,
J D Farquhar, and W A Hankins, and A N Desanctis, and J L Demeio, and D P Metzgar
Adverse events after polysaccharide meningococcal A&C vaccine.
January 1998, Scandinavian journal of infectious diseases,
J D Farquhar, and W A Hankins, and A N Desanctis, and J L Demeio, and D P Metzgar
Clinical and serological evaluation of a Pasteurella haemolytica A1 capsular polysaccharide vaccine.
January 1993, Vaccine,
J D Farquhar, and W A Hankins, and A N Desanctis, and J L Demeio, and D P Metzgar
Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents.
August 2019, Vaccine,
Copied contents to your clipboard!